Oncosem Onkolojik Sistemler Sanayi ve Ticaret AS (ONCSM)

Currency in TRY
95.30
-0.05(-0.05%)
Closed·

ONCSM Financial Summary

Key Ratios

P/E Ratio-1,018.26
Price/Book6.57
Debt / Equity12.67%
Return on Equity-0.74%
Dividend Yield0.00%
EBITDA50.11M
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of TRY (except for per share items)

Earnings

Latest Release
May 05, 2025
EPS / Forecast
0.32 / --
Revenue / Forecast
167.74M / --
EPS Revisions
Last 90 days

FAQ

What were Oncosem Onkolojik Sistemler Sanayi's earnings for the latest quarter?

The Oncosem Onkolojik Sistemler Sanayi EPS (TTM) is -0.08. Oncosem Onkolojik Sistemler Sanayi reported sales of 167.74, net income of 7.53, and EPS of 0.32 for the latest quarter.

What was Oncosem Onkolojik Sistemler Sanayi's net income for the latest quarter?

Oncosem Onkolojik Sistemler Sanayi's net income for the latest quarter was 7.53.

How did Oncosem Onkolojik Sistemler Sanayi's performance compare year-over-year in the latest quarter?

The company's revenue moved from 96.55 in the previous quarter to 167.74 in the latest quarter, and net income moved from -9.57 to 7.53 compared to the previous quarter.

What is Oncosem Onkolojik Sistemler Sanayi's net profit margin on a TTM basis?

Oncosem Onkolojik Sistemler Sanayi's trailing twelve months (TTM) net profit margin is -15.80%.

How does Oncosem Onkolojik Sistemler Sanayi's debt to equity ratio compare to industry standards?

Oncosem Onkolojik Sistemler Sanayi's total debt-to-equity ratio is 12.67%.

What is Oncosem Onkolojik Sistemler Sanayi's return on investment on a TTM basis?

Oncosem Onkolojik Sistemler Sanayi's trailing twelve months (TTM) return on investment (ROI) is -0.74%.

Did Oncosem Onkolojik Sistemler Sanayi gain or lose cash last quarter?

In the latest quarter, Oncosem Onkolojik Sistemler Sanayi's net change in cash was -7.93 million.

What were Oncosem Onkolojik Sistemler Sanayi's total assets and liabilities in the latest quarter?

As of the latest quarter, Oncosem Onkolojik Sistemler Sanayi reported total assets of 426.43 million and total liabilities of 70.40 million.

How has Oncosem Onkolojik Sistemler Sanayi's total revenue grown this year?

Oncosem Onkolojik Sistemler Sanayi's total revenue was 96.55 in the previous quarter and 167.74 in the latest quarter.

What is Oncosem Onkolojik Sistemler Sanayi's gross margin on a TTM basis?

Oncosem Onkolojik Sistemler Sanayi's trailing twelve months (TTM) gross margin is 44.52%.

What was Oncosem Onkolojik Sistemler Sanayi's revenue per share for the latest quarter?

Oncosem Onkolojik Sistemler Sanayi's revenue per share for the latest quarter was 12.93.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.